Obsidian Therapeutics Company
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Connections from
Last Funding Type:
Series B
Industry:
Gene therapy
Founded Date:
1/1/2015
Employee Number:
51-100
Total Funding:
164500000
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Early Stage Venture